AVOCENT CORP·4

Feb 9, 5:07 PM ET

AVOCENT CORP 4

4 · AVOCENT CORP · Filed Feb 9, 2004

Insider Transaction Report

Form 4
Period: 2004-02-05
DAMBRACKAS WILLIAM A
Exec VP, Advanced Technology
Transactions
  • Award

    Common Stock

    2004-02-05+20,00020,000 total
    Exercise: $40.98From: 2004-02-05Exp: 2014-02-05Common Stock (20,000 underlying)
Holdings
  • Common Stock

    1,698
  • Options (rights to buy)

    Exercise: $27.25From: 2003-03-07Exp: 2013-03-07Common Stock (30,000 underlying)
    30,000
  • Options (rights to buy)

    Exercise: $22.36From: 2001-05-25Exp: 2011-05-25Common stock (4,500 underlying)
    4,500
  • Options (rights to buy)

    Exercise: $29.31From: 2001-01-03Exp: 2011-01-03Common Stock (31,500 underlying)
    31,500
  • Options (rights to buy)

    Exercise: $21.77From: 2002-04-15Exp: 2012-04-15Common Stock (9,000 underlying)
    9,000
Footnotes (2)
  • [F1]Grant date, 15% vests every six months for the first 12 months, 6.25% vests quarterly for the following 24 months and 5% vests quarterly for the remaining 12 months.
  • [F2]Grant date, 25% vests after 6 months and in 10 equal quarterly installments thereafter.

Documents

1 file
  • 4
    edgar.xmlPrimary

    FORM 4 -